drugset / Trial / NCT05752461
SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of the study is to evaluate the efficacy and safety of SHR-2004 in preventing venous thromboembolism after elective unilateral total knee arthroplasty
Timeline
- Start
- 2023-04-12
- Primary completion
- 2024-04-12
- Completion
- 2024-06-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |
| Subject | SHR-2004 | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.